StockData
EDVANYSEBeveragesFiscal year ends December 31

Endovia Health Sciences, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.14−0.01 (-7.53%)

Close on Oct 19, 2026

Market cap
$413.76K
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 20, 2026Before market open–––
Q2 FY2023
Ended Jun 30, 2023
Aug 16, 2023After market close$5.20M$-0.13–
Q3 FY2022
Ended Sep 30, 2022
Nov 17, 2022During market hours–––
Q2 FY2022
Ended Jun 30, 2022
Aug 16, 2022After market close–––
Q1 FY2022
Ended Mar 31, 2022
May 17, 2022After market close–––
Q3 FY2021
Ended Sep 30, 2021
Nov 17, 2021During market hours–––
Q2 FY2021
Ended Jun 30, 2021
Aug 18, 2021During market hours–––
Q1 FY2021
Ended Mar 31, 2021
May 14, 2021After market close–––
Q3 FY2020
Ended Sep 30, 2020
Nov 17, 2020After market close–––
Q2 FY2020
Ended Jun 30, 2020
Aug 18, 2020After market close–––

Press releases

Announcements Endovia Health Sciences filed with the SEC